Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme
Condition

Vici syndrome

Congenital Malformations and Chromosomal Abnormalities

Vici syndrome, also called immunodeficiency with cleft lip or palate, cataract, hypopigmentation and absent corpus callosum, is a rare autosomal recessive congenital disorder. It is characterized by albinism, agenesis of the corpus callosum, cataracts, cardiomyopathy, severe psychomotor retardation, seizures, immunodeficiency and recurrent severe infections. About 50 cases have been reported to date, which makes it one of the rarer multisystem genetic syndromes described in the medical literature.

Facts
Classification
Body System
Nervous System 1
Body System
Cardiovascular System 1
Body System
Lymphatic or Immune System 1
Body System
Eye 1
ICD-10 Chapter
XVII: Congenital Malformations, Deformations and Chromosomal Abnormalities 2
Communicable or Non-communicable
Non-Communicable 1
Causative Agent
Causative Agent (category)
Genetic / Hereditary 1
Sources
1. Vici syndrome (Wikipedia)
  • Lead, first paragraph
    rare autosomal recessive congenital disorder
  • Lead, first paragraph [body-system]
    agenesis of the corpus callosum
  • Lead, first paragraph [body-system 2]
    cataracts
  • Lead, first paragraph [body-system 3]
    cardiomyopathy
  • Lead, first paragraph [body-system 4]
    immunodeficiency and recurrent severe infections
  • Lead: disease category
    Vici syndrome, also called immunodeficiency with cleft lip/palate, cataract, hypopigmentation and absent corpus callosum (or absent corpus callosum cataract immunodeficiency), is a rare autosomal recessive congenital disorder characterized by albinism, agenesis of the corpus callosum, cataracts, cardiomyopathy, severe psychomotor retardation, seizures, immunodeficiency and recurrent severe infections.
View the Source
2. World Health Organization ICD-10: ICD-10 Version:2019 - Q80-Q89
World Health Organization ICD-10Category Q87.8
Quote, Category Q87.8
Q87.8 Other specified congenital malformation syndromes,
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.